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Abstract 
The decline in adaptive immunity, naïve T-cell output and a contraction in the peripheral T 
cell receptor (TCR) repertoire with age are largely attributable to thymic involution and the 
loss of critical cytokines and hormones within the thymic microenvironment. To assess the 
molecular changes associated with this loss of thymic function, we used cDNA microarray 
analyses to examine the transcriptomes
 of thymocytes from mice of various ages ranging 
from very young (1 month) to very old (24 months). Genes associated with various bio-
logical and molecular processes including oxidative phosphorylation, T- and B- cell receptor 
signaling and antigen presentation were observed to significantly change with thymocyte age. 
These include several immunoglobulin chains, chemokine and ribosomal proteins, annexin 
A2, vav 1 and several S100 signaling proteins. The increased expression of immunoglobulin 
genes in aged thymocytes could be attributed to the thymic B cells which were found to be 
actively producing IgG and IgM antibodies. Upon further examination, we found that purified 
thymic T cells derived from aged but not young thymi also exhibited IgM on their cell surface 
suggesting the possible presence of auto-antibodies on the surface thymocytes with ad-
vancing age. These studies provide valuable insight into the cellular and molecular mecha-
nisms associated with thymic aging. 
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Introduction 
The aging immune system is often characterized 
by a general decline in the ability to resist infection 
and an increase in autoimmune complications such as 
type 2 diabetes, inflammation, and cancer [1-9]. One 
of the underlying causes of the reduced effectiveness 
of the immune system with age is the involution of the 
thymus. As the thymus involutes, there is a resulting 
decrease in naïve T cell output, and consequently 
memory T cells occupy a larger portion of the pe-
r i p h e r a l  T  c e l l  p o o l  [ 1 0 - 1 6 ] .  H o w e v e r ,  t h i s  l o s s  i n  
thymic output with age does not result in any sig-
nificant change in the total number of peripheral T 
cells. The maintenance of peripheral T-cell numbers 
appears to be regulated via a thymus-independent 
homeostatic process involving expansion of mature 
peripheral T cells which results in a much more lim-
ited T-cell receptor (TCR) repertoire with age. While 
the precise mechanism(s) facilitating thymic involu-Int. J. Med. Sci. 2009, 6 
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tion has yet to be determined, it appears that this 
thymic loss is an active process involving a variety of 
factors including the loss and apoptosis of the thy-
mocytes and supportive cell populations within the 
microenvironment, alterations in the appropriate 
signals from supporting stromal and epithelial cells, 
diminished progenitor cell recruitment and expansion 
and a decrease in steroid signaling essential for thy-
mocyte development [17-25]. Other factors which are 
yet to be identified may also be involved. Given that 
the loss in thymic function is one of the earliest and 
most consistent steps in the progression to immune 
dysfunction, thymic involution seems to be a most 
promising target for therapeutic intervention to re-
verse thymic atrophy and restore thymic function.  
Given that the aged thymus consists of large ar-
eas of fat and connective tissue [26, 27], we have fo-
cused our efforts on performed DNA array analysis 
specifically on isolated thymocyte populations in or-
der to obtain a clearer picture of which genes or gene 
families may demonstrate altered expression levels 
with age. Our results demonstrate that genes associ-
ated with various biological and molecular processes 
including oxidative phosphorylation, T- and B- cell 
receptor signaling and antigen presentation were ob-
served to significantly change with thymocyte age. 
Interesting, the expression of several immunoglobulin 
chains were also found to be significantly increased in 
aged thymocytes. Understanding the changes in gene 
expression in thymocytes with age may hold the key 
in determining thymocyte fate and decreased thymic 
output with age.  
Materials and Methods 
 Mice. Specific pathogen-free C57BL/6 mice of 
various ages were purchased through the Office of 
Biological Resources and Resource Development of 
the National Institute on Aging (Bethesda, MD). All 
mice were maintained in an AAALAC-certified bar-
rier facility and were acclimated for 2 weeks prior to 
use. All mice were fed autoclaved food and water ad 
libitum. All mice with evidence of disease (e.g., 
enlarged spleen, gross tumors) were not utilized in 
these studies.  
 Thymocyte  isolation.  Freshly-extracted thymi 
from mice of various ages were dissociated in RPMI 
using a syringe and forceps. Cell clumps were broken 
up with repeated pipetting and then poured through 
70μm nylon mesh cell strainers (BD Falcon, Bedford, 
MA) to remove connective tissue and any remaining 
clumps. The cells were washed once to remove fat 
cells, which will float to the top rather than pelleting 
at the bottom with the thymocytes. The red blood cells 
then were lysed with ammonium chloride buffer. The 
remaining thymocyte population, which reflects the 
actual interactive environment of the thymus, was 
counted, washed twice in RPMI followed by PBS. The 
cell pellets were either used directly in the Qiagen 
RNEasy mini kits for RNA preparation or lysed in 
RIPA buffer containing protease and phosphatase 
inhibitors (Sigma, St Louis, MO) to use in Western 
blot analysis, or resuspended in the appropriate 
buffer for whatever assay was used following cell 
preparation.  
In certain experiments, thymocytes were mag-
netically labeled using the Pan T cell isolation kit, then 
passed through LD magnetic cell separation columns 
(Miltenyi Biotec, Auburn, CA), to separate them into T 
cell and non-T cell subsets. RNA was then isolated 
from these cell subsets using the Qiagen RNEasy Mini 
Kit as described below, and used for real-time 
RT-PCR as described above. 
 RNA extraction and array analysis. For each array 
sample, the RNA was prepared from the purified 
thymocytes. The thymocytes were processed by using 
the RNEasy Mini Kit (Qiagen, Valencia, CA). Quality 
and quantity of total RNA samples was assessed us-
ing an Agilent 2100 Bioanalyzer (Agilent Technolo-
gies, Palo Alto, CA). This total RNA was used to gen-
erate fluorescent cRNA for use with Agilent’s oli-
gonucleotide microarrays. The RNA was amplified 
and labeled using the Agilent Low RNA Input Fluo-
rescent Linear Amplification Kit following manufac-
tures protocols. In Short: Between 0.5μg to 2μg of total 
RNA was used to generate first and second strands of 
cDNA containing a T7 RNA polymerase promoter. 
Then cRNA was synthesized using T7 RNA poly-
merase which simultaneously incorporates cyanine 3- 
or cyanine 5- labeled CTP (Perkin Elmer, Wellesley, 
MA). Qiagen RNeasy columns (Qiagen Valencia, CA) 
were used to purify the labeled cRNA and the final 
concentration was assessed using a Nanodrop 
ND-1000 spectrophotometer (Nanodrop Technolo-
gies, Wilmington, DE). 750 ng of Cy3-labeled cRNA 
and 750 ng of Cy5-labeled control sample were com-
bined with spiked in control probes specific for targets 
on the arrays and hybridized over night at 600C to 
Agilent Mouse Whole Genome 44K Oligo Microarrays 
(Agilent Technologies, Palo Alto, CA). The arrays 
were washed at room temperature 6X SSC with 
0.005% Triton X-102 for 10 minutes and 0.01x SSC 
with 0.005% Triton X-102 at 40C for 5 minutes. The 
slides were then dried in a nitrogen stream and 
scanned at 10 micron resolution using an Agilent Mi-
croarray scanner G2565BA. Data was extracted using 
Agilent Feature Extractor Software (v7.1). 
 Statistical data analysis. All data was processed a 
Z score statistical analysis method developed at NIA Int. J. Med. Sci. 2009, 6 
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[28]. In order to be selected for the final gene list, the 
expression value of a particular gene had to be at least 
1.5 times different from the Z score of the control. 
Differences were considered statistically significant 
only if they had a p value less than 0.01.  
  Gene expression profiles. The selected gene lists 
were uploaded along with their Z scores to the Mi-
croarray Data Analysis website of the National Hu-
man Genome Research Institute 
(http://arrayanalysis.nih.gov/). Using dis-
tance-based gene selection, gene expression profiles 
were created in order to visualize differences between 
age, gender and diet.  
 Real-time  PCR.  Array results were verified by 
semi-quantitative RT-PCR. One-half to one micro-
gram of RNA from thymocyte samples were used to 
make cDNA with the iScript cDNA synthesis kit (Bio-
Rad, Hercules, CA). One microliter of each cDNA 
sample was then used to measure quantity using the 
SYBR Green PCR master mix (Applied Biosystems) 
and reactions were run on the 7500 fast or 7300 PCR 
system (Applied Biosystems). The results were nor-
malized to 18S using the QuantumRNA universal 18S 
(Ambion, Austin, TX) and were also used to deter-
mine relative quantities. The primers are shown in 
Table 4. 
 Western blot analysis. Equal amounts of protein 
from thymocytes were run on 10% tris-glycine gels 
and transferred to PVDF membranes (Invitrogen, 
Carlsbad, CA) on the Novex gel-blot system (Invitro-
gen, Carlsbad, CA). The nitrocellulose filters were 
then probed using HRP-conjugated specific antibod-
ies to the immunoglobulin heavy chain M (IgM) and 
IgG obtained from Abcam (Cambridge, MA). The 
antibody to beta-actin was from Sigma-Aldrich (St. 
Louis, MO). The HRP-conjugated secondary antibody 
for the beta-actin was from Amersham (Piscataway, 
NJ). Bands were visualized using the ECL Plus west-
ern blotting detection reagents (Amersham) and CL-X 
Posure film from Pierce (Rockford, IL). 
 Flow cytometry. Cell suspensions were washed in 
HBSS with 0.1% BSA and 0.1% sodium azide 
(Sigma-Aldrich, St. Louis, MO). Antibody against Fc 
receptors was used to block non-specific binding (BD 
Biosciences, San Jose, CA). Cells were stained ex-
tracellularly for B220 (BD) ten minutes on ice and ei-
ther simultaneously stained for extracellular IgM 
(Caltag, Carlsbad, CA), or subsequently stained for 
intracellular IgM. For intracellular staining, the cells 
were fixed in PBS containing 2% paraformaldehyde 
(Sigma-Aldrich) and washed twice in PBS with 0.03% 
saponin to permeabilize the cell membranes. 
Anti-IgM was added for 30 minutes at 4 degrees, and 
then the cells were washed twice in PBS with sodium 
azide. The stained cells were then run on a FACScan 
flow cytometer (BD) and the data analyzed using Cell 
Quest software (BD).  
Results 
  Gene expression changes were identified by 
comparing gene expression profiles across the indi-
cated age groups to the gene expression profiles of the 
1 month age group (Figure 1). While the numbers of 
genes with decreased expression were fairly consis-
tent throughout the three older ages, the number of 
genes with increased expression peaked in the 
16-month age group. Table 1 lists the canonical cellu-
lar pathways affected by changes in gene expression 
levels with thymocytes age. This list was generated by 
uploading the list of genes with the most significant 
changes to the Ingenuity Analysis website 
(http://www.ingenuity.com/). Table 1A lists all 
pathways affected at any age group. As would be 
expected, these included pathways involved in lym-
phocyte receptor signaling and antigen presentation. 
Genes involved in oxidative phosphorylation were 
the most numerous regardless of age group. Pathways 
involving purine metabolism, PI3/Akt signaling, and 
ubiquinone synthesis are the ones most affected dur-
ing aging (Table 1B). All of these pathways are in-
volved in cell survival [29-33], and deficiencies in the 
ubiquinone pathway have already been linked to in-
creased longevity in mice [34].  
 
Figure 1. Number of genes at each age group with expression 
levels higher or lower than levels exhibited by the 1 month age 
group. The bars labeled total show the total number of all 
genes changed at all ages. Red bars depict the number of 
genes which increased expression levels and green bars 
depict the number of genes which decreased expression 
levels. Int. J. Med. Sci. 2009, 6 
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Table 1. Canonical pathways containing thymocyte genes which 
changed expression levels with age. These pathways were 
identified by the ingenuity data analysis program 
(www.ingenuity.com) using our uploaded data. 
ALL CHANGES AT ALL AGES 
CANONICAL PATHWAYS  NUMBER of GENES p  VALUE 
Oxidative Phosphorylation  18  0.001 
T Cell Receptor Signaling  15  1.2 x 10-5 
Antigen Presentation  14  4.7 x 10-8 
B Cell Receptor Signaling  14  0.007 
Purine Metabolism  14  NS 
G Protein Coupled Receptor  13  0.001 
Integrin Signaling  13  0.17 
Erk/MAPK Signaling  11  0.10 
PI3/Akt Signaling  10  0.03 
Apoptosis Signaling  9  0.017 
 
CHANGES at 24 MONTHS 
CANONICAL PATHWAYS  NUMBER of GENES p  VALUE 
Oxidative Phosphorylation  11  6.8 x 10-4 
Purine Metabolism  9  2.0 x 10-1 
Antigen Presentation  8  7.6 x 10-6 
TCR Signaling  6  9.7 x 10-3 
PI3/Akt Signaling  6  2.4 x 10-2 
Ubiquinone Synthesis  4  3.1 x 10-2 
 
 
  Pathway analysis (www.ingenuity.com) identi-
fied signaling pathways and gene families that were 
affected in aging thymocytes. Table 2A lists all af-
fected functions regardless of age and Table 2B lists 
the functions most affected at the oldest age group 
and highlighted groups of genes involved in immune 
response, development and disease. In the oldest age 
group, the functional category including the most 
genes was cell-to-cell signaling and interaction, which 
could play a key role in thymocyte survival or death 
associated with age. Many genes associated with 
cancer are also affected in aging thymocytes. Given 
the increased incidence of cancer with age [7, 35, 36] 
(http://www.nia.nih.gov/ResearchInforma-
tion/ConferencesAndMeetings/WorkshopReport/Fi
gure1.htm), this may be a valuable group of genes 
warranting further scrutiny.   
   In order to obtain an expression profile of the 
genes which changed the most with age, we uploaded 
all of our array data into the array analysis program of 
the NHGRI (http://arrayanalysis.nih.gov). Table 3 
lists the top genes that were up- or down-regulated 
with age. A. A complete list of all genes that changed 
with age is available on request. Most of the genes 
with the greatest increase were immunoglobu-
lin-associated genes. This was a very interesting 
finding, given that the number of immunoglobu-
lin-producing cells within the thymus is actually quite 
limited. In order to identify genes that can discrimi-
nate among aging versus young thymocytes, we sub-
jected our array data to distance-based analysis. Fig-
ure 2 shows the top 100 genes with significant differ-
ences in expression levels at all ages. The most notable 
aspect of the profile is the fact that all 100 genes ex-
hibiting the greatest differences with age actually in-
creased in expression. In light of these results, we fo-
cused our attention on genes demonstrating increased 
transcription, more specifically several of the immu-
noglobulin-associated genes found to be up-regulated 
in their expression in thymocytes with age. As shown 
in Table 4, real time RT-PCR confirmed the increased 
levels of many of these genes identified in the array 
analysis. Moreover, Western blot analysis of thymo-
cyte lysates also confirmed that IgM increases with 
age (Figure 3). Flow cytometry analysis shows that 
there is also a modest age-associated increase in the 
percentage of IgM+/B220+ B cells within the thymus 
and that this increase in IgM is both extra- and in-
tra-cellular (Figure 4).   
 
Table 2. Functional categories containing thymocyte genes 
which changed expression levels with age. These groups were 
identified by the ingenuity data analysis program 
(www.ingenuity.com) using our uploaded data. 
ALL CHANGES AT ALL AGES 
GENE FUNCTION NUMBER  of 
GENES 
p VALUE 
Hematological System Development 
and Function 
48  3.82 x 10-4 
Immune and Lymphatic System 
Development and Function 
45  3.82 x 10-4 
Cell-to-Cell Signaling and Interaction 42  8.00 x 10-3 
Cancer  32  3.44 x 10-4 
Immune Response  31  2.40 x 10-2 
Small Molecule Biochemistry  22  9.52 x 10-3 
DNA Replication, Recombination 
and Repair 
20  2.48 x 10-2 
 
CHANGES at 24 MONTHS 
GENE FUNCTION NUMBER  of 
GENES 
p VALUE 
Cell-to-Cell Signaling and Interaction 22  0.016 
Hematological System Development 
and Function 
18 0.012 
Immune and Lymphatic System 
Development and Function 
17 0.010 
Small Molecule Biochemistry  16  0.005 
Cellular Assembly and Organization  16  0.023 
Cancer 15  0.010 
Cellular Function and Maintenance  14  0.001 
Cell Cycle  13  9.52 x 10-3 
Immunological Disease  12  0.002 
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Figure 2.  Expression 
profile of the most sig-
nificantly changed genes 
with age. This profile 
was generated in the 
NHGRI website 
(https://arrayanalysis.ni
h.gov), using dis-
tance-based analysis of 
total data and showing 
the top 100 changed 
genes. Red represents 
up-regulation of gene 
expression, and green 
represents down regu-
lation of gene expres-
sion. 
 Int. J. Med. Sci. 2009, 6 
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Table 3. Top genes that increased or decreased with age. This table lists the Z ratios at each age for the genes with the greatest 
differences in expression levels when comparing the oldest age group, 24 months, to the youngest, 1 month. As can be seen, 
most of the genes which increased expression levels are immunoglobulin-associated. 
GENE NAMES  GENE 
NAME 
ENTREZ 
GENE 
UNIGENE Z  Ratio 
6M-1M 
Z Ratio 
16M-1M 
Z Ratio 
24M-1M 
Similar to Ig heavy-chain region precursor  LOC380800  380800    3.74 13.81  12.67 
Mus musculus kappa light chain of Mab7 mRNA, 
partial cds 
AF152371    Mm.333124 .55 9.02  7.98 
S25058 Ig kappa chain- mouse, partial (86%) 
[TC1067460] 
S25058     2.04 6.89 6.85 
Immunoglobulin kappa chain  LOC545854  545854  Mm.426205 0.60  6.34  6.38 
Immunoglobulin joining chain  IgJ  16069  Mm.1192  1.64  7.26  6.32 
Immunoglobulin heavy chain 6 (heavy chain of IgM)  Igh-6    Mm.342177 0.15 4.50 5.16 
Immunoglobulin kappa chain variable 28 (V28)  IgK-V28  16114  Mm.333124 1.76  7.14  5.07 
RIKEN cDNA 3110049J23  9130427K04  67307  Mm.368563 4.61  3.67  5.06 
RIKEN cDNA 5730437N04  5730437N04Rik 70544  Mm.46654  5.20  5.88  4.79 
Similar to Ig lambda-1 chain C region  J00582  433053  J00582  1.66  6.52  4.63 
RIKEN cDNA B230118H07  Rag1/Nwc 
fusion 
68170  Mm.31263  -2.49 -2.26 -2.62 
Mus musculus mRNA for Zfp-1 zinc finger protein 
[X16493] 
Zfp1  22640  Mm.4184  -3.09 -2.34 -2.72 
Mus musculus CDC28 protein kinase regulatory sub-
unit 2 
Cks2  33197  Mm.222228 -3.27 -3.26 -2.76 
Mus musculus cytochrome C oxidase subunit VIIb 
mRNA [NM_025379] 
Cox7b 66142  Mm.197728 -1.92 -3.39 -2.83 
Integrin beta 3 binding protein (beta3-endonexin)  Itgb3bp    Mm.257094 -2.15 -2.93 -2.95 
Mus musculus BCL-2 modifying factor homolog , 
A430110F10 
Bmf  171543  Mm.210125 -3.30 -3.42 -2.96 
Membrane metallo-endopeptidase-like 1  Mmel1  27390    -3.11 -3.76 -3.88 
Mus musculus chemokine (C-C motif) ligand 25 
(Ccl25) mRNA 
Ccl25  20300  Mm.7275  -7.31 -6.14 -4.31 
Mus musculus S100 calcium binding protein A9 (cal-
granulin B) 
S100a9 20202  Mm.2128  -8.16 -2.66 -9.39 
Mus musculus S100 calcium binding protein A (cal-
granulin B) 
S100a8 20201  Mm.21567  -8.99 -3.76 -10.12 
 
 
 
Table 4. Real-time RT-PCR confirmation of genes up-regulated with age in the DNA array. This table lists a series of confirmations 
of array results using real-time RT-PCR. Many of the down-regulated genes were difficult to confirm, probably due to already 
low levels of expression. Up-regulated immunoglobulin-associated genes were easily confirmed and validated the array 
results for that group of genes. 
ARRAY RESULTS 
 
PCR 
Results 
 
GENE NAME 
 
Gene ID 
 
Gene 
Name 
(zratio) 
6m-1m 
(zratio) 
16m-1m
(zratio) 
24m-1m
Fold 
Change
24M-1M
 
Forward Primer 
 
Reverse Primer 
kappa light 
chain of Mab7 
mRNA, partial 
cds 
AF152371 IgKV1, 
IgKVK 
0.55 9.02  7.98  57*  ACCAAGCTGGAAATC
AATCG 
TGTCGTTCACTGCCATCAAT 
immunoglobu-
lin joining chain 
(Igj) 
NM_152839 Igj  1.53  6.83  5.83  38*  AAGCGACCATTCTTG
CTGAC 
GGGAGGTGGGATCAGAGATA
TT 
histocompatibil-
ity 2, class II 
antigen A, beta 1 
(H2-Ab1) 
NM_010379 H2-Ab
1 
2.51 4.72  4.53  3.3 TTCATCCGTCACAGG
AGTCA 
AGGAATTCGGAGCAGAGAC
A 
chemokine 
(C-X-C motif) 
receptor 6 
(Cxcr6) 
NM_030712 Cxcr6  2.49  7.91  3.98  4.7*  AACAGCCAGGAGAA
CAAACG 
GGGCAAGTTCAGCAGAAACA
decorin (Dcn)  NM_007833  Dcn  1.84  4.40  3.88  13  ACCCTGACAATCCCC GCCCCTTCTTTGATCTCTGT Int. J. Med. Sci. 2009, 6 
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ARRAY RESULTS 
 
PCR 
Results 
 
GENE NAME 
 
Gene ID 
 
Gene 
Name 
(zratio) 
6m-1m 
(zratio) 
16m-1m
(zratio) 
24m-1m
Fold 
Change
24M-1M
 
Forward Primer 
 
Reverse Primer 
TGATA 
Mus musculus 
immunoglobu-
lin heavy chain 
6 (heavy chain 
of IgM) 
BC018315 IgH6  0.75  4.41 3.89 14  ATGGAATGGACCTGG
GTCTT 
ATGTCCAGGCCTCTGCTTTA 
ribosomal pro-
tein, large, P1 
(Rplp1) 
NM_018853 Rplp1  3.90  3.49  3.78  4.7  CACGGAGGATAAGAT
CAATGC 
ATGAGGCTCCCAATGTTGAC 
acidic ribosomal 
phosphoprotein 
P0 (Arbp) 
NM_007475 Arbp  3.38  3.79  3.78  77*  TCGTTGGAGTGACAT
CGTCT 
GCTCCCACAATGAAGCATTT 
Actin, cyto-
plasmic 1 
(Beta-actin) 
NAP018710-0
01 
B-actin 2.78  2.14  3.51  NC  CTAAGGCCAACCGTG
AAAAG 
CCATCACAATGCCTGTGGTA 
Mouse MHC 
class I 
H2-K-alpha-2 
gene (haplotype 
bm9), partial 
exon 3 
M13200 H2K1  1.57  4.52  3.42  NC  AAGAGCGATGAGCAG
TGGTT 
CCACGTTTTCAGGTCTTCGT 
cytochrome c 
oxidase subunit 
II (Cox2) 
AF378830 Cox2  3.07  3.66 3.25 NC TAATTGCTCTCCCCTC
TCTACG 
CACCAGGTTTTAGGTCGTTTG
annexin A2 
(Anxa2) 
NM_007585 Anxa2  3.01  3.15  3.25  2.5*  ACGAAATCCTGTGCA
AGCTC 
ATCCCTCTCAGCATCGAAGT 
CD8 antigen, 
beta chain 
(Cd8b) 
NM_009858 Cd8b  2.27  2.23  2.32  3.8  ACGAAGCTGACTGTG
GTTGA 
AAGCAGGATGCAGACTACCA
vav 1 oncogene 
(Vav1) 
NM_011691 Vav1  1.99  2.12  1.90  3.2*  CGAACCTTCCTGTCTA
CTTGCT 
TTCCTTTGTTCTGGGCAATG 
chemokine 
(C-X-C motif) 
receptor 4 
(Cxcr4) 
NM_009911 Cxcr4  1.82  1.75  1.72  3.5*  TTGCCATGGAACCGA
TCA 
TCCGTCATGCTCCTTAGCTT 
phosphoinosi-
tide 3-kinase 
regulatory sub-
unit p85alpha 
U50413 U5041
3 
1.73 1.80  1.63  NC  CCCAAGCTGGATGTG
AAGTT 
TTTCCTGGGAAGTACGGGTGT
A 
 
 
 
 
 
 
 
 
Figure 3. Protein levels of immunoglobulin increase within the thymocytes with age. Western blot analysis of IgM heavy chain 
protein levels with successive age. This image is representative of 3 experiments with at least 7 total young and old samples.  Int. J. Med. Sci. 2009, 6 
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Figure 4. Flow cytometry confirms an increase in IgM+ cells with age within the thymus. There are greater relative percentages 
of both surface and intracellular IgM in the old thymocytes when compared to the young. Flow cytometry images are 
representative of at least 2 experiments using 5 young and 6 old mice. 
 
 
In humans, thymic B cells increase with age [37] as well as in some autoimmune diseases such as myas-
thenia gravis [38]. Other groups have characterized small populations of B cells within the thymus (Akashi et al., 
2000; Mori et al., 1997 [39, 40]. These B cells are B220 low and IgM negative [40]. They appear to mature within 
the thymus, and produce IgM largely from the IgH6 family, which was the IgM group that showed the greatest 
increase in expression with age in our array system. Ultimately, as these cells mature, they begin to express CD5 
on their surfaces [40]. It is possible that the increase in B cells we observe with age is a result of an increase in the 
maturation of these thymic B cells. If this is the case, perhaps we would see correlating increases in genes which 
facilitate B cell maturation. With this in mind, we examined the mRNA expression levels of BAFF and APRIL 
within the thymocytes. These two genes are expressed by cells of lymphoid lineage, and are linked to increased 
B cell proliferation, maturation and survival [41-43]. They are specifically involved in the progression from the 
T1 to T2 stages of immature B cells. We observed that both of these genes are elevated in expression in the old 
thymocytes when compared to the young by real-time RT-PCR (Figure 5). These genes thus may be a contrib-
uting factor to the increase in B cells, both in total number and in maturity, within the thymus.  
The increase in B cell numbers in the thymus with age seems too small to account for the greatly increased 
quantities of immunoglobulin expression as determined by real time PCR and Western analyses. Therefore, we 
also looked at other cell types which could be producing immunoglobulin within the thymus, such as plasma 
cells. However, we found that plasma cells were not contributing to the increased production of immunoglobu-
lin with age, as flow cytometric analysis for B220, CD38 and CD138 on the thymocytes as well as RT-PCR 
analysis for the plasma cell markers, blimp1 and XBP1, failed to demonstrate any significant differences in ex-
pression levels with age (Figure 6). There is also no relative increase in the size of the B1 B cell population with Int. J. Med. Sci. 2009, 6 
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age as assessed by flow cytometric analysis of the B220/CD5 populations, although we do see a minute, but 
statistically significant difference in the CD5 negative, IgM positive population (Figure 7).  
 
 
Figure 5. Real-time RT-PCR analysis reveals increased levels of mRNA expression of BAFF and APRIL in aged thymocytes. BAFF and 
APRIL are both involved in maturation and survival of B cells, and their expression levels are elevated in aged thymocytes 
when compared to the levels in young thymocytes. This correlates with the increase in B cells detected with age. These 
Figures represent one experiment with six mice in each age group. 
 
 
Figure 6. A) CD138 analysis by 
flow cytometry demonstrates 
that there is no difference in the 
percentages of plasma cells in 
thymocytes from young and old 
mice. Averages of CD138
+B220
- 
cells are 1.12% and 1.07%, re-
spectively. These Figures are 
representative of three experi-
ments with a total of 10 young 
and 10 old mice. B) If plasma cell 
numbers increase in old thymi, an 
increase in Blimp1 and XBP1 
expression and a decrease in 
BCL6 should be observed. 
Real-time RT-PCR quantitation 
of plasma cell markers XBP1 and 
BCL6 show no differences be-
tween young and old thymocytes. 
Blimp1 RNA was too low to be 
detected in any of our thymocyte 
samples, although positive con-
trols were detectable.  
 Int. J. Med. Sci. 2009, 6 
 
http://www.medsci.org 
60
 
Figure 7. CD5 analysis by flow cytometry demonstrates that there is no difference in the percentages of B1 B cells in 
thymocytes from young and old mice. Averages of CD5
+IgM
+ cells are 0.12% and 0.29%, respectively. These Figures are 
representative of two experiments with a total of 5 young and 6 old mice. 
 
Surprisingly, we did observe a shift in the fluo-
rescence intensity of IgM on the surfaces of aged 
CD4+ and CD8+ thymocytes (Figure 8). Given that 
immunoglobulins are not associated with T cells, it 
was of interest to determine if the increase in IgM 
expression by older thymocytes was due to actual 
production by thymic T cells or non-T cell popula-
tions. To this end, we separated the cells into T and 
non-T subsets using the pan T-cell isolation kit and 
magnetic columns from Miltenyi. We then isolated the 
RNA from each group of cells, and this RNA was 
used for real-time RT-PCR to determine the relative 
amounts of IgM being produced by young and old 
thymocytes. As shown in Figure 9, the majority of the 
IgM production in the thymus originates from the 
non-T cell populations. Since the only increase in 
immunoglobulin production detected in the aged 
samples was associated with B220+ B cells within the 
thymus (as previously shown by flow cytometry, 
Figure 4), it appears that the increased production of 
immunoglobulin detected in DNA microarrays and 
PCR within the aged thymocytes is a reflection of the 
generalized increased output of antibodies by B cells 
in the aged thymus. Given that the actual number of 
circulating B cells within the thymus is very small, 
even slight alterations in immunoglobulin expression 
may be detected as significant. The large concentra-
tion of immunoglobulin protein detected within the 
thymus by Western blot may also be amplified by the 
presence of circulating auto-antibodies bound to 
thymic T cell surfaces as suggested by Figure 8. 
  Further evidence supporting the presence of 
auto-antibodies bound to the surface of thymic T cells 
can be observed in Figure 10. CD3+ positive thymo-
cytes have a slightly higher fluorescence intensity for 
surface IgM in the old samples when compared to the 
young (Figure 10A). This shift in intensity is not evi-
dent in the same cells stained for intracellular IgM 
(Figure 10B), meaning these are not the cells produc-
ing the IgM; it is merely binding on their cell surfaces. 
Attempts to elute and isolate these antibodies have 
proven quite difficult and more intensive studies are 
underway to examine these thymic T cell-bound an-
tibodies. 
 
 
 
Figure 8. CD4
+ and CD8
+ T cells in the thymus exhibit an 
increase in cell surface IgM with age. Red lines designate the 
young samples and blue lines the old samples. Flow cy-
tometry demonstrates that there is a clear shift in the mean 
fluorescence intensity of IgM in the old thymocytes when 
compared to the young thymocytes. This indicates a greater 
number of IgM molecules on the cell surfaces. These data 
are representative of 3 separate experiments with 3 to 7 
mice in each group. Int. J. Med. Sci. 2009, 6 
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Figure 9.  Real-time RT-PCR results of IgH6 RNA relative 
quantities from total non-fractionated thymocytes and T cell and 
non-T cell fractions from column-separated thymocytes. Thy-
mocytes were separated by magnetic columns into T cell 
and non-T cell fractions. RNA isolated from these samples 
was then used in real-time RT-PCR analysis of IgG heavy 
chain transcription. This clearly demonstrates that all of the 
immunoglobulin production appears to be occurring in the 
non-T cells within the thymus. Similar results were obtained 
for IgH6, H2-Ab1 and IgJ. These data are representative of 
four experiments using pooled thymocytes from at least 3 
mice of each age group. 
 
 
 
Figure 10. CD3
+ cells of the thymus exhibit a shift in mean 
fluorescence intensity with age, indicating an increased presence 
of IgM on their surfaces. (A). However, this phenomenon is 
not evident intracellularly (B), indicating the IgM comes 
from a source outside of those cells. Data shown is for 
CD4
+ cells. Similar results were obtained for CD8
+ cells. 
Red lines represent young samples and blue lines represent 
old samples. These data are representative of two ex-
periments using pooled thymocytes form 3 young and 3 to 5 
old mice in each experiment. 
Discussion 
 There are a myriad of complications arising from 
the weakening of the effectiveness of the immune 
system with age [1-9]. One of the most prominent 
landmarks of the aging immune systems is the invo-
lution of the thymus, which results in decreased 
thymic output of nascent T cells [10-16]. Many theo-
ries have been examined as to why this involution 
occurs with advancing age [18, 44, 45]; however, little 
is known about the molecular changes that occur 
within the thymus and in thymocytes with age. Here, 
we have examined the actual interactive thymocyte 
populations derived from C57BL/6 mice after re-
moval of fat and connective tissue, at various stages of 
aging using microarray gene analysis. These thymo-
cytes represent the actual relative composition of the 
thymus at the various ages and thus are better suited 
to understanding how the relative dynamics of sub-
populations may affect thymic aging. At least 600 
genes were found to vary in expression levels when 
compared to the 1-month age group. From these 
analyses, there were also twice as many genes with 
increased gene expression as there were demonstrat-
ing decreased expression. Moreover, genes demon-
strating increased expression levels were consistently 
of higher statistical significance than those with de-
creased levels. This is more likely a reflection of the 
difference in the sensitivity of the assay than a repre-
sentation of an actual bias toward increased gene ex-
pression levels within biological systems with age. As 
would be expected, genes involved in immune sig-
naling pathways such as B and T cell receptor signal-
ing and antigen presentation were among the path-
ways containing the largest number of genes chang-
ing with age. The canonical pathway with the largest 
number of detected genes was the oxidative phos-
phorylation pathway. This is not surprising, given 
that oxidative phosphorylation controls the energy 
levels within the cells and is directly linked to lym-
phocyte survival as well as changes in the redox 
status of aging organisms [46-49]. Thus, this group of 
pathways may be vital to thymocyte survival or death 
during thymic involution. Both the PI3/Akt and 
ubiquinone synthesis pathways contained a relatively 
large number of genes which changed expression 
levels with age and both of these pathways have also 
been shown to affect cell survival [50-54]. There were 
large numbers of genes involved in the hematological, 
immune and lymphatic systems, which vary from 
control levels at 1 month. Another category of 
up-regulated genes were associated with cell-to-cell 
signaling and interaction, important processes in de-Int. J. Med. Sci. 2009, 6 
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termining cell fate, and likely to be involved in thymic 
selection and output.  
The individual genes demonstrating the most 
significant and highest levels of age-associated dif-
ferences in expression were the immunoglobu-
lin-associated genes. These genes included several 
heavy and light chain sequences. Although not de-
finitively identified, it is interesting to speculate that 
these genes are not only associated with the increased 
numbers of B cells within the aging thymus but also 
may be associated with the production of 
auto-antibodies to thymic subsets (as shown in Fig-
ures 8 and 10). Such auto-antibodies have been dem-
onstrated to increase with age [18, 55-57]. Of the top 
genes that decreased with age, two were S100 signal-
ing proteins, which are very important in T cell sig-
naling and survival [58-60]. Such decreased expres-
sion may result in a diminished capacity for thymo-
cytes activate, differentiate and/or survive. 
 The large number of immunoglobulin genes that 
changed with age was quite surprising as there are 
few antibody-producing cells in the thymus, even 
with advancing age. Western blot analysis of IgM 
quantities demonstrated levels of IgM heavy chain in 
the thymocytes of 24-month-old mice as high as in the 
spleen of 1-month-old mice. The source of these large 
quantities of immunoglobulin is still unclear. Al-
though flow cytometry analysis displayed increased 
numbers of IgM+B220+ B cells (average 1% in young 
vs. 5% in old), the total numbers of cells did not ap-
pear to reflect the amount of change detected by ar-
ray, PCR and western blot. Therefore, we looked at 
other cell types within the thymus that may be pro-
ducing immunoglobulin. There were no detectable 
increases in plasma cells or CD5+ B1 B cells in the 
thymi of young and aged mice as measured by flow 
cytometric analysis [61, 62]. The increase in IgM posi-
tive cells we observed does not appear to be within 
the CD5+ population (Figure 7) that has been identi-
fied as maturing within the thymus [40]. They could 
represent a separate B cell population that matures 
and increases in number within the thymus with in-
creased age. Thymic B cells may play a role in T cell 
negative selection [63]. These B cells express IgM on 
their surface and are thus of a more mature pheno-
type. Since these are the ones we observe increasing 
with age within the thymus, it would be interesting to 
speculate that this may be another factor contributing 
to thymic involution with age. 
 Interestingly, flow cytometric analysis did indi-
cate the presence of IgM on the surface of both CD4+ 
and CD8+ T cells within the thymus. Obviously, it is 
highly unlikely that this T-cell associated immu-
noglobulin reflects actual production of IgM by aging 
T cells but is more likely membrane bound IgM due to 
an increase in the levels of circulating auto-antibodies 
adhering to the T cell surface [64]. Additional flow 
cytometric analysis revealed that although there was a 
shift in the surface IgM mean fluorescence intensity 
on thymic T cells with age, this increase was not in-
tracellular and thus was bound to the cell surface 
suggesting the presence of autoantibody. Further tests 
are necessary to determine the exact nature of this 
binding. The phenomenon of age-associated increase 
in auto-antibodies has been well documented [18, 
55-57] and these auto-antibodies could influence 
thymic involution. This shift in IgM mean fluores-
cence intensity in aged murine T cells has also been 
previously described [64]. Together, these data sug-
gest that increased numbers of thymic B cells and 
auto-antibodies may be associated with aging in 
thymocytes and that autoimmune interactions may 
play important roles in thymocyte death and thymic 
involution.  
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